 "Eris Lifesciences to make bourse debut on June 29")
New Delhi: Eris Lifesciences is set to debut on the stock market on Thursday after concluding its initial public offer (IPO) last week.  The company’s IPO was subscribed 3.29 times during 16-20 June. The portion set aside for qualified institutional buyers (QIBs) was oversubscribed 4.68 times, non institutional investors 45 percent and retail investors 3.51 times. The price band for the share sale was fixed at Rs600- 603. The book running lead managers to the offer were Axis Capital, Citigroup Global Markets India and Credit Suisse Securities (India). Eris Lifesciences is into manufacturing of branded pharmaceutical products in select therapeutic areas
End of Article
 "US ready to ‘impose costs’ on Russia if war in Ukraine drags on, says Hegseth")
 "US tells Hamas to stop violence against Gaza civilians and disarm 'without delay'")
 "China seizes 60,000 maps mislabelling Taiwan, omitting South China Sea islands")
 "Syria’s Sharaa pledges to honor Russia ties, seeks economic and military support in Kremlin visit")
 "US ready to ‘impose costs’ on Russia if war in Ukraine drags on, says Hegseth")
 "US tells Hamas to stop violence against Gaza civilians and disarm 'without delay'")
 "China seizes 60,000 maps mislabelling Taiwan, omitting South China Sea islands")
 "Syria’s Sharaa pledges to honor Russia ties, seeks economic and military support in Kremlin visit")
](https://images.firstpost.com/wp-content/uploads/2017/06/bsebuilding1-reuters.jpg){kind=link}